Serum Activin A Levels and Renal Outcomes After Coronary Angiography

Sci Rep. 2020 Feb 25;10(1):3365. doi: 10.1038/s41598-020-60359-x.

Abstract

Prevention for contrast-induced nephropathy (CIN) is limited by the lack of a single predictor. As activin A is upregulated in heart failure and chronic kidney disease, we aimed to clarify the association between activin A levels and renal outcomes after coronary angiography (CAG). This prospective observational study included 267 patients who received CAG between 2009 and 2015. CIN was defined as elevation of serum creatinine to >0.5 mg/dL or to >25% above baseline within 48 hours after CAG. During follow-up, laboratory parameters were measured every 3-6 months. Renal decline was defined as>2-fold increase in serum creatinine or initiation of dialysis. The patients were stratified into tertiles according to serum activin A levels at baseline. High activin A tertile was significantly associated more CIN and renal function decline compared to low activin A tertile (all p < 0.001). After adjusting potential confounding factors, high serum activin A tertiles was associated to CIN (Odds ratio 4.49, 95% CI 1.07-18.86, p = 0.040) and renal function decline (Hazard ratio 4.49, 95% CI 1.27-11.41, p = 0.017) after CAG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activins / blood*
  • Aged
  • Contrast Media / administration & dosage
  • Coronary Angiography
  • Creatinine / metabolism
  • Female
  • Heart Failure / blood*
  • Heart Failure / diagnostic imaging
  • Heart Failure / physiopathology
  • Humans
  • Kidney / diagnostic imaging
  • Kidney / metabolism*
  • Kidney / pathology
  • Male
  • Middle Aged
  • Prospective Studies
  • Renal Dialysis
  • Renal Insufficiency, Chronic / blood*
  • Renal Insufficiency, Chronic / diagnostic imaging
  • Renal Insufficiency, Chronic / physiopathology
  • Risk Factors

Substances

  • Contrast Media
  • activin A
  • Activins
  • Creatinine